These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26690127)

  • 1. Use of Inotropic Agents in Treatment of Systolic Heart Failure.
    Tariq S; Aronow WS
    Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
    Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D
    Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure.
    Liu LC; Dorhout B; van der Meer P; Teerlink JR; Voors AA
    Expert Opin Investig Drugs; 2016; 25(1):117-27. PubMed ID: 26587768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction.
    Psotka MA; Teerlink JR
    Handb Exp Pharmacol; 2017; 243():465-490. PubMed ID: 28315072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W; Pauschinger M; Ertl G
    Clin Res Cardiol; 2016 Jun; 105(6):471-81. PubMed ID: 26879807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropes in Patients with Advanced Heart Failure: Not Only Palliative Care.
    Masarone D; Melillo E; Gravino R; Errigo V; Martucci ML; Caiazzo A; Petraio A; Pölzl G; Pacileo G
    Heart Fail Clin; 2021 Oct; 17(4):587-598. PubMed ID: 34511207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotropes in the management of acute heart failure.
    Petersen JW; Felker GM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list.
    Hübner T; Nickel T; Steinbeck G; Massberg S; Schramm R; Reichart B; Hagl C; Kiwi A; Weis M
    Clin Res Cardiol; 2015 Nov; 104(11):929-34. PubMed ID: 25841881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments targeting inotropy.
    Maack C; Eschenhagen T; Hamdani N; Heinzel FR; Lyon AR; Manstein DJ; Metzger J; Papp Z; Tocchetti CG; Yilmaz MB; Anker SD; Balligand JL; Bauersachs J; Brutsaert D; Carrier L; Chlopicki S; Cleland JG; de Boer RA; Dietl A; Fischmeister R; Harjola VP; Heymans S; Hilfiker-Kleiner D; Holzmeister J; de Keulenaer G; Limongelli G; Linke WA; Lund LH; Masip J; Metra M; Mueller C; Pieske B; Ponikowski P; Ristić A; Ruschitzka F; Seferović PM; Skouri H; Zimmermann WH; Mebazaa A
    Eur Heart J; 2019 Nov; 40(44):3626-3644. PubMed ID: 30295807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status of Inotropes in Heart Failure.
    Ginwalla M; Tofovic DS
    Heart Fail Clin; 2018 Oct; 14(4):601-616. PubMed ID: 30266368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.
    Kalogeropoulos AP; Marti CN; Georgiopoulou VV; Butler J
    J Card Fail; 2014 Aug; 20(8):593-601. PubMed ID: 24879975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).
    Aljundi AHS; Mohammed SFK; Patel A; Singh R; Arabi A; AlBinali HA; Al Suwaidi J
    BMC Cardiovasc Disord; 2016 Feb; 16():47. PubMed ID: 26892533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.
    Cleland JG; Teerlink JR; Senior R; Nifontov EM; Mc Murray JJ; Lang CC; Tsyrlin VA; Greenberg BH; Mayet J; Francis DP; Shaburishvili T; Monaghan M; Saltzberg M; Neyses L; Wasserman SM; Lee JH; Saikali KG; Clarke CP; Goldman JH; Wolff AA; Malik FI
    Lancet; 2011 Aug; 378(9792):676-83. PubMed ID: 21856481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inotropic therapy in heart failure: general aspects and clinical results].
    Manito N; Kaplinsky EJ; Pujol R
    Med Clin (Barc); 2004 Feb; 122(7):269-74. PubMed ID: 15012878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
    Farmakis D; Agostoni P; Baholli L; Bautin A; Comin-Colet J; Crespo-Leiro MG; Fedele F; García-Pinilla JM; Giannakoulas G; Grigioni F; Gruchała M; Gustafsson F; Harjola VP; Hasin T; Herpain A; Iliodromitis EK; Karason K; Kivikko M; Liaudet L; Ljubas-Maček J; Marini M; Masip J; Mebazaa A; Nikolaou M; Ostadal P; Põder P; Pollesello P; Polyzogopoulou E; Pölzl G; Tschope C; Varpula M; von Lewinski D; Vrtovec B; Yilmaz MB; Zima E; Parissis J
    Int J Cardiol; 2019 Dec; 297():83-90. PubMed ID: 31615650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.